Showing results 1 to 6 of 6
Enhancement of the photocytotoxic efficiency of sub-12 nm therapeutic polymeric micelles with increased co-localisation in mitochondria Chong, Kyuha; Ku, Tae-Yun; Saw, Phei Er; Jon, Sang-Yong; Park, Ji-Ho; Choi, Chul-Hee, CHEMICAL COMMUNICATIONS, v.49, no.98, pp.11476 - 11478, 2013-12 |
Extra-domain B of fibronectin as an alternative target for drug delivery and a cancer diagnostic and prognostic biomarker for malignant glioma Saw, Phei Er; Xu, Xiaoding; Kang, Bo Ram; Lee, Jungsul; Lee, Yeo Song; Kim, Chungyeul; Kim, Hyungsin; et al, THERANOSTICS, v.11, no.2, pp.941 - 957, 2021-01 |
Harnessing type I interferon-mediated immunity to target malignant brain tumors Lim, Juhee; Kang, In; La, Jeongwoo; Ku, Keun Bon; Kang, Byeong Hoon; Kim, Yumin; Park, Won Hyung; et al, FRONTIERS IN IMMUNOLOGY, v.14, 2023-05 |
New advances in CMV and immunosenescence Sansoni, Paolo; Vescovini, Rosanna; Fagnoni, Francesco F.; Akbar, Arne; Arens, Ramon; Chiu, Yen-Ling; Cicin-Sain, Luka; et al, EXPERIMENTAL GERONTOLOGY, v.55, pp.54 - 62, 2014-07 |
Past, Present, and Future of Brain Organoid Technology Koo, Bonsang; Choi, Baekgyu; Park, Hoewon; Yoon, Ki-Jun, MOLECULES AND CELLS, v.42, no.9, pp.617 - 627, 2019-09 |
Spatial immune heterogeneity of hypoxia-induced exhausted features in high-grade glioma Kim, A-Reum; Choi, Seong Jin; Park, Junsik; Kwon, Minsuk; Chowdhury, Tamrin; Yu, Hyeon Jong; Kim, Sojin; et al, ONCOIMMUNOLOGY, v.11, no.1, 2022-12 |
Discover